Align Technology | ALGN - Current Liabilities

Stock Price
189.59
Daily Change
-1.08 -0.57%
Monthly
5.17%
Yearly
3.40%
Q2 Forecast
185.89

Align Technology reported $1.92B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
3M USD 9.03B 563M Mar/2026
Align Technology USD 1.92B 46.45M Dec/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Bruker USD 1.28B 11.1M Dec/2025
Cardinal Health USD 43.31B 3.05B Dec/2025
Charles River Laboratories USD 1.12B 1.57M Dec/2025
Cooper Companies USD 1.6B 482.9M Dec/2025
CVS Health USD 88.69B 4B Dec/2025
Danaher USD 7.46B 653M Mar/2026
Dentsply International USD 1.34B 62M Dec/2025
Dexcom USD 2.14B 1.19B Dec/2025
Henry Schein USD 3.23B 79M Dec/2025
Idexx Laboratories USD 1.15B 103M Dec/2025
Insulet USD 680.1M 32.4M Dec/2025
Integra LifeSciences USD 455.98M 91.93M Dec/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Masimo USD 371.6M 1.9M Dec/2025
McKesson USD 68.13B 100M Dec/2025
Mettler Toledo International USD 1.2B 5.99M Dec/2025
Revvity USD 1.33B 108.5M Dec/2025
Solventum Corp USD 3.14B 198M Dec/2025
Stryker USD 7.79B 380M Dec/2025
Teleflex USD 762.03M 11.01M Dec/2025
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Veeva Systems USD 1.64B 692.18M Dec/2025
Waters USD 1.24B 11.8M Dec/2025
Zimmer Biomet Holdings USD 2.58B 180.8M Dec/2025
Zoetis USD 2.24B 428M Dec/2025